V-Med | Tesamorelin 30mg | Compound Peptide Vial
Advanced Growth Hormone Releasing Hormone (GHRH) Research Compound
V-MED Tesamorelin is an investigational peptide research compound classified as a growth hormone releasing hormone (GHRH) analogue, widely studied in laboratory settings for its role in pituitary signalling pathways and growth hormone regulation mechanisms.
Tesamorelin has been referenced in scientific research exploring lipid metabolism regulation, endocrine signalling, and growth hormone secretion dynamics within controlled experimental environments.
Developed as a 30mg peptide vial formulation, this compound is designed for laboratory preparation and controlled research use where endocrine pathway analysis and hormonal signalling studies are of scientific interest.
V-MED Tesamorelin 30mg Compound Peptide Vial
• GHRH analogue research compound studied in endocrine pathway models
• Investigated in growth hormone signalling and secretion research
• Of interest in lipid metabolism and metabolic regulation studies
• Explored in pituitary function and hormonal feedback mechanisms
• 30mg vial format designed for laboratory preparation use
• High-purity investigational formulation from V-MED
• Manufactured for stability, consistency, and research reliability
• Strictly intended for laboratory research use only
⚖️ DISCLAIMER
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPHRA) for human or animal use.
This product is supplied strictly for laboratory research purposes only and is not intended for human consumption.
Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease.
By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.
